![logo](/logos/KPTI.webp)
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
0.73 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Karyopharm Therapeutics Inc. |
Symbool | KPTI |
Munteenheid | USD |
Prijs | 0.73 |
Beurswaarde | 91,044,257 |
Dividendpercentage | 0% |
52-weken bereik | 0.617 - 1.95 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Richard A. Paulson M.B.A. |
Website | https://www.karyopharm.com |
An error occurred while fetching data.
Over Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)